

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.54226934 |
| 2 | mannose metabolic process (GO:0006013) | 3.28867557 |
| 3 | glutamate secretion (GO:0014047) | 3.25870193 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 3.25349454 |
| 5 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.08108752 |
| 6 | positive regulation of protein dephosphorylation (GO:0035307) | 2.81065829 |
| 7 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.80423794 |
| 8 | signal complex assembly (GO:0007172) | 2.78377842 |
| 9 | modulation by symbiont of host cellular process (GO:0044068) | 2.78130181 |
| 10 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.77413409 |
| 11 | modulation by virus of host process (GO:0019054) | 2.75772727 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.75188159 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.75188159 |
| 14 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.75002640 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.74568569 |
| 16 | desmosome organization (GO:0002934) | 2.72806485 |
| 17 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.69976758 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.62934535 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.62934535 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 2.62934535 |
| 21 | positive regulation by symbiont of host defense response (GO:0052509) | 2.62934535 |
| 22 | modulation by symbiont of host defense response (GO:0052031) | 2.62934535 |
| 23 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.62934535 |
| 24 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.62448740 |
| 25 | regulation of early endosome to late endosome transport (GO:2000641) | 2.61961165 |
| 26 | positive regulation of synapse maturation (GO:0090129) | 2.59248829 |
| 27 | regulation of cholesterol storage (GO:0010885) | 2.56917173 |
| 28 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.56246564 |
| 29 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.54108679 |
| 30 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.53412657 |
| 31 | regulation of extracellular matrix disassembly (GO:0010715) | 2.52143914 |
| 32 | activation of MAPKKK activity (GO:0000185) | 2.48271742 |
| 33 | activation of Rac GTPase activity (GO:0032863) | 2.47633026 |
| 34 | oxygen transport (GO:0015671) | 2.47521762 |
| 35 | cerebellar granule cell differentiation (GO:0021707) | 2.46000278 |
| 36 | negative regulation of cell killing (GO:0031342) | 2.44327808 |
| 37 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.44327808 |
| 38 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.43894786 |
| 39 | sodium ion export (GO:0071436) | 2.43443654 |
| 40 | response to laminar fluid shear stress (GO:0034616) | 2.40861807 |
| 41 | positive regulation of receptor recycling (GO:0001921) | 2.40783022 |
| 42 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.38239289 |
| 43 | detection of bacterium (GO:0016045) | 2.38119650 |
| 44 | gas transport (GO:0015669) | 2.37851768 |
| 45 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.36705721 |
| 46 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.36569232 |
| 47 | macrophage activation involved in immune response (GO:0002281) | 2.35939022 |
| 48 | detection of other organism (GO:0098543) | 2.35920648 |
| 49 | negative regulation of fatty acid transport (GO:2000192) | 2.33515508 |
| 50 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.33131039 |
| 51 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.33017508 |
| 52 | barbed-end actin filament capping (GO:0051016) | 2.32969406 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.32756892 |
| 54 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.30783437 |
| 55 | positive regulation of interferon-alpha production (GO:0032727) | 2.29851593 |
| 56 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.29438887 |
| 57 | stress fiber assembly (GO:0043149) | 2.29376739 |
| 58 | regulation of necrotic cell death (GO:0010939) | 2.28257901 |
| 59 | endothelial cell chemotaxis (GO:0035767) | 2.26704590 |
| 60 | protein targeting to plasma membrane (GO:0072661) | 2.26704152 |
| 61 | immunoglobulin mediated immune response (GO:0016064) | 2.25711630 |
| 62 | positive regulation of extracellular matrix organization (GO:1903055) | 2.25704663 |
| 63 | L-amino acid import (GO:0043092) | 2.25264090 |
| 64 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.25199088 |
| 65 | hemidesmosome assembly (GO:0031581) | 2.23591078 |
| 66 | adenosine receptor signaling pathway (GO:0001973) | 2.23427394 |
| 67 | regulation of regulated secretory pathway (GO:1903305) | 2.21545861 |
| 68 | focal adhesion assembly (GO:0048041) | 2.19910322 |
| 69 | cell-substrate adherens junction assembly (GO:0007045) | 2.19910322 |
| 70 | adherens junction assembly (GO:0034333) | 2.19548996 |
| 71 | semaphorin-plexin signaling pathway (GO:0071526) | 2.19406079 |
| 72 | regulation of interferon-alpha production (GO:0032647) | 2.18965385 |
| 73 | myelin maintenance (GO:0043217) | 2.18856908 |
| 74 | regulation of extracellular matrix organization (GO:1903053) | 2.18562082 |
| 75 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.17292125 |
| 76 | regulation of protein dephosphorylation (GO:0035304) | 2.17058941 |
| 77 | regulation of leukocyte degranulation (GO:0043300) | 2.16642740 |
| 78 | regulation of ARF protein signal transduction (GO:0032012) | 2.16274380 |
| 79 | cell-substrate junction assembly (GO:0007044) | 2.14815964 |
| 80 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.14777892 |
| 81 | response to host (GO:0075136) | 2.14777892 |
| 82 | response to host defenses (GO:0052200) | 2.14777892 |
| 83 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.14644294 |
| 84 | synaptic vesicle maturation (GO:0016188) | 2.14324836 |
| 85 | response to type I interferon (GO:0034340) | 2.13381952 |
| 86 | myeloid dendritic cell differentiation (GO:0043011) | 2.13267685 |
| 87 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.11912714 |
| 88 | response to muramyl dipeptide (GO:0032495) | 2.11610627 |
| 89 | actin filament polymerization (GO:0030041) | 2.11191496 |
| 90 | activation of JUN kinase activity (GO:0007257) | 2.09823785 |
| 91 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.08276076 |
| 92 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.07873162 |
| 93 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.07788203 |
| 94 | regulation of Rap GTPase activity (GO:0032317) | 2.07183240 |
| 95 | type I interferon signaling pathway (GO:0060337) | 2.07151540 |
| 96 | cellular response to type I interferon (GO:0071357) | 2.07151540 |
| 97 | protein localization to endosome (GO:0036010) | 2.06294150 |
| 98 | detection of external biotic stimulus (GO:0098581) | 2.06003611 |
| 99 | modulation by virus of host morphology or physiology (GO:0019048) | 2.05892836 |
| 100 | cortical actin cytoskeleton organization (GO:0030866) | 2.05482692 |
| 101 | positive regulation of antigen processing and presentation (GO:0002579) | 2.04389036 |
| 102 | regulation of cholesterol homeostasis (GO:2000188) | 2.04209070 |
| 103 | lymphocyte chemotaxis (GO:0048247) | 2.04175119 |
| 104 | positive thymic T cell selection (GO:0045059) | 2.04163031 |
| 105 | cellular response to virus (GO:0098586) | 2.04010452 |
| 106 | regulation of ARF GTPase activity (GO:0032312) | 2.03347184 |
| 107 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.03206393 |
| 108 | mature B cell differentiation (GO:0002335) | 2.02696754 |
| 109 | positive regulation of type 2 immune response (GO:0002830) | 2.01959452 |
| 110 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.00394300 |
| 111 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.00127368 |
| 112 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 1.99732194 |
| 113 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 1.99704004 |
| 114 | myeloid dendritic cell activation (GO:0001773) | 1.98522277 |
| 115 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 1.98388781 |
| 116 | megakaryocyte development (GO:0035855) | 1.97686061 |
| 117 | germinal center formation (GO:0002467) | 1.97628414 |
| 118 | cellular potassium ion homeostasis (GO:0030007) | 1.97255554 |
| 119 | positive regulation of histone deacetylation (GO:0031065) | 1.96847633 |
| 120 | positive regulation of cholesterol efflux (GO:0010875) | 1.96044783 |
| 121 | regulation of type 2 immune response (GO:0002828) | 1.95414650 |
| 122 | negative regulation of type 2 immune response (GO:0002829) | 1.95269886 |
| 123 | B cell receptor signaling pathway (GO:0050853) | 1.94423570 |
| 124 | apoptotic cell clearance (GO:0043277) | 1.93452330 |
| 125 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 1.92926802 |
| 126 | response to peptidoglycan (GO:0032494) | 1.92671091 |
| 127 | negative regulation of interleukin-8 production (GO:0032717) | 1.92450083 |
| 128 | negative regulation of T-helper cell differentiation (GO:0045623) | 1.91575903 |
| 129 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 1.91575903 |
| 130 | myeloid cell activation involved in immune response (GO:0002275) | 1.90672049 |
| 131 | hydrogen peroxide biosynthetic process (GO:0050665) | 1.89655477 |
| 132 | tolerance induction (GO:0002507) | 1.89390932 |
| 133 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 1.88559795 |
| 134 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 1.87808838 |
| 135 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 1.87511068 |
| 136 | leukocyte aggregation (GO:0070486) | 1.82282171 |
| 137 | thymic T cell selection (GO:0045061) | 1.81755922 |
| 138 | granulocyte activation (GO:0036230) | 1.81211741 |
| 139 | myeloid cell development (GO:0061515) | 1.81030583 |
| 140 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 1.78414536 |
| 141 | regulation of gamma-delta T cell differentiation (GO:0045586) | 1.77541063 |
| 142 | regulation of gamma-delta T cell activation (GO:0046643) | 1.77493783 |
| 143 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 1.77336760 |
| 144 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 1.77187006 |
| 145 | regulation of antigen processing and presentation (GO:0002577) | 1.76193203 |
| 146 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 1.75966594 |
| 147 | negative regulation of lipid storage (GO:0010888) | 1.75857204 |
| 148 | respiratory burst (GO:0045730) | 1.75371537 |
| 149 | neutrophil activation involved in immune response (GO:0002283) | 1.75252514 |
| 150 | regulation of T cell tolerance induction (GO:0002664) | 1.75112147 |
| 151 | neutrophil activation (GO:0042119) | 1.75001247 |
| 152 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 1.74801879 |
| 153 | lymphocyte migration (GO:0072676) | 1.73948099 |
| 154 | positive regulation of Rap GTPase activity (GO:0032854) | 1.73642717 |
| 155 | leukocyte cell-cell adhesion (GO:0007159) | 1.73077378 |
| 156 | response to host immune response (GO:0052572) | 1.72745854 |
| 157 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 1.72745854 |
| 158 | neuronal action potential propagation (GO:0019227) | 1.72012177 |
| 159 | regulation of cellular amide metabolic process (GO:0034248) | 1.72006969 |
| 160 | response to fungus (GO:0009620) | 1.71988472 |
| 161 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 1.71315739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.30178750 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.63040991 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.58313121 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.25396400 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.19266994 |
| 6 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.17916712 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.17430839 |
| 8 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.16607783 |
| 9 | * MYC_22102868_ChIP-Seq_BL_Human | 1.93990536 |
| 10 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.93832238 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.87018407 |
| 12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86517882 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.82133903 |
| 14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.79458442 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.77781536 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.74590838 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72501249 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67706481 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67379083 |
| 20 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.65745609 |
| 21 | GATA1_19941826_ChIP-Seq_K562_Human | 1.65129101 |
| 22 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.63655324 |
| 23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.60705973 |
| 24 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.59824998 |
| 25 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.58897138 |
| 26 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.58595754 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.57222738 |
| 28 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.56069966 |
| 29 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.55794115 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.54851229 |
| 31 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.53880148 |
| 32 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.53877259 |
| 33 | * P68_20966046_ChIP-Seq_HELA_Human | 1.52900371 |
| 34 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.52798946 |
| 35 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.52461475 |
| 36 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.51931929 |
| 37 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.49864391 |
| 38 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.49488181 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.49356415 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48682951 |
| 41 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.48663170 |
| 42 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.48219570 |
| 43 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.47819788 |
| 44 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.47818276 |
| 45 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.43044139 |
| 46 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.42046607 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.40891408 |
| 48 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.40152128 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.39500888 |
| 50 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.39290597 |
| 51 | GATA2_19941826_ChIP-Seq_K562_Human | 1.38912089 |
| 52 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.35384565 |
| 53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35028546 |
| 54 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.34829810 |
| 55 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33166514 |
| 56 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31009021 |
| 57 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30585566 |
| 58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29766515 |
| 59 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.29294049 |
| 60 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.29199193 |
| 61 | MAF_26560356_Chip-Seq_TH1_Human | 1.29094088 |
| 62 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.28321570 |
| 63 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.27864030 |
| 64 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27287936 |
| 65 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.26587812 |
| 66 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.25993632 |
| 67 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25811328 |
| 68 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23905577 |
| 69 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.23863676 |
| 70 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.23484267 |
| 71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23255422 |
| 72 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.22845584 |
| 73 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21586257 |
| 74 | * MAF_26560356_Chip-Seq_TH2_Human | 1.21133461 |
| 75 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.20704982 |
| 76 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20084137 |
| 77 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.18988274 |
| 78 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18756055 |
| 79 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.18057672 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17868203 |
| 81 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17509288 |
| 82 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.17276487 |
| 83 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17031799 |
| 84 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.16860577 |
| 85 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13434383 |
| 86 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09300358 |
| 87 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08773535 |
| 88 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08659906 |
| 89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06907225 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06823762 |
| 91 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.06700066 |
| 92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06311704 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05869276 |
| 94 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.05624687 |
| 95 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.05182446 |
| 96 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.04718717 |
| 97 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.03879533 |
| 98 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03773774 |
| 99 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03213103 |
| 100 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.02635792 |
| 101 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02493666 |
| 102 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.02418051 |
| 103 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.02418051 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01707490 |
| 105 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01431978 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01361564 |
| 107 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00715929 |
| 108 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00580659 |
| 109 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.99863148 |
| 110 | SA1_27219007_Chip-Seq_Bcells_Human | 0.99698138 |
| 111 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.99687341 |
| 112 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99051467 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99019560 |
| 114 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.98912257 |
| 115 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.97602905 |
| 116 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.97552478 |
| 117 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.97476354 |
| 118 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.97387945 |
| 119 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97149349 |
| 120 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97087834 |
| 121 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96734674 |
| 122 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.96692077 |
| 123 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96134902 |
| 124 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95704281 |
| 125 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95686421 |
| 126 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95400769 |
| 127 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95345353 |
| 128 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.95006065 |
| 129 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94845130 |
| 130 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.93070780 |
| 131 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92800842 |
| 132 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.90978502 |
| 133 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.90448628 |
| 134 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.89245470 |
| 135 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.88460846 |
| 136 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87741849 |
| 137 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.87555938 |
| 138 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.87555424 |
| 139 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87533802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.36012138 |
| 2 | MP0002822_catalepsy | 2.68577027 |
| 3 | MP0003300_gastrointestinal_ulcer | 2.57120411 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 2.47379332 |
| 5 | MP0004510_myositis | 2.46194130 |
| 6 | MP0003172_abnormal_lysosome_physiology | 2.38470133 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.35089784 |
| 8 | MP0005387_immune_system_phenotype | 2.25041126 |
| 9 | MP0001790_abnormal_immune_system | 2.25041126 |
| 10 | MP0003436_decreased_susceptibility_to | 2.18090001 |
| 11 | MP0005451_abnormal_body_composition | 2.09847246 |
| 12 | MP0000685_abnormal_immune_system | 2.01294604 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 1.97014249 |
| 14 | MP0005000_abnormal_immune_tolerance | 1.94803003 |
| 15 | MP0009785_altered_susceptibility_to | 1.93903474 |
| 16 | MP0003075_altered_response_to | 1.93788034 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 1.91592193 |
| 18 | MP0004947_skin_inflammation | 1.90766085 |
| 19 | MP0003724_increased_susceptibility_to | 1.88365266 |
| 20 | MP0004859_abnormal_synaptic_plasticity | 1.84387293 |
| 21 | MP0003866_abnormal_defecation | 1.83011387 |
| 22 | MP0005025_abnormal_response_to | 1.80954544 |
| 23 | MP0005409_darkened_coat_color | 1.80054246 |
| 24 | MP0001835_abnormal_antigen_presentation | 1.79269541 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.74834996 |
| 26 | MP0005167_abnormal_blood-brain_barrier | 1.74329205 |
| 27 | MP0002419_abnormal_innate_immunity | 1.68706057 |
| 28 | MP0005257_abnormal_intraocular_pressure | 1.67158605 |
| 29 | MP0005310_abnormal_salivary_gland | 1.66488505 |
| 30 | MP0008260_abnormal_autophagy | 1.65408742 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.64483662 |
| 32 | MP0000678_abnormal_parathyroid_gland | 1.63760897 |
| 33 | MP0001800_abnormal_humoral_immune | 1.63179813 |
| 34 | MP0003453_abnormal_keratinocyte_physiol | 1.62263257 |
| 35 | MP0003045_fibrosis | 1.59348467 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.57091041 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.56172322 |
| 38 | MP0002723_abnormal_immune_serum | 1.53422775 |
| 39 | MP0003879_abnormal_hair_cell | 1.51946361 |
| 40 | MP0009379_abnormal_foot_pigmentation | 1.51841410 |
| 41 | MP0002796_impaired_skin_barrier | 1.44806133 |
| 42 | MP0001819_abnormal_immune_cell | 1.44520831 |
| 43 | MP0001873_stomach_inflammation | 1.43505766 |
| 44 | MP0002420_abnormal_adaptive_immunity | 1.42397216 |
| 45 | MP0005166_decreased_susceptibility_to | 1.42087770 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.39699299 |
| 47 | MP0001849_ear_inflammation | 1.37423958 |
| 48 | MP0003279_aneurysm | 1.36248524 |
| 49 | MP0003690_abnormal_glial_cell | 1.32852438 |
| 50 | * MP0005671_abnormal_response_to | 1.32126986 |
| 51 | MP0004381_abnormal_hair_follicle | 1.31130248 |
| 52 | MP0001958_emphysema | 1.28669453 |
| 53 | MP0004858_abnormal_nervous_system | 1.27141907 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.26620659 |
| 55 | MP0005076_abnormal_cell_differentiation | 1.25455421 |
| 56 | MP0006082_CNS_inflammation | 1.24975139 |
| 57 | MP0001348_abnormal_lacrimal_gland | 1.24071517 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.23738957 |
| 59 | MP0003091_abnormal_cell_migration | 1.21880092 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.17573435 |
| 61 | MP0008961_abnormal_basal_metabolism | 1.16781856 |
| 62 | MP0001663_abnormal_digestive_system | 1.15334091 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.14651218 |
| 64 | MP0002249_abnormal_larynx_morphology | 1.14603834 |
| 65 | MP0009840_abnormal_foam_cell | 1.14170233 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 1.12856329 |
| 67 | MP0005023_abnormal_wound_healing | 1.11783873 |
| 68 | MP0004185_abnormal_adipocyte_glucose | 1.08971878 |
| 69 | MP0005375_adipose_tissue_phenotype | 1.08584118 |
| 70 | MP0001501_abnormal_sleep_pattern | 1.07967648 |
| 71 | MP0000604_amyloidosis | 1.07247715 |
| 72 | MP0002405_respiratory_system_inflammati | 1.06665614 |
| 73 | MP0002877_abnormal_melanocyte_morpholog | 1.06243724 |
| 74 | MP0005083_abnormal_biliary_tract | 1.05932055 |
| 75 | MP0005666_abnormal_adipose_tissue | 1.04989263 |
| 76 | MP0008874_decreased_physiological_sensi | 1.04782715 |
| 77 | MP0001545_abnormal_hematopoietic_system | 1.04190019 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 1.04190019 |
| 79 | MP0002138_abnormal_hepatobiliary_system | 1.03491736 |
| 80 | MP0002254_reproductive_system_inflammat | 1.03221830 |
| 81 | MP0002060_abnormal_skin_morphology | 1.02594593 |
| 82 | MP0002909_abnormal_adrenal_gland | 1.00876635 |
| 83 | MP0002089_abnormal_postnatal_growth/wei | 1.00489753 |
| 84 | MP0003566_abnormal_cell_adhesion | 0.99533864 |
| 85 | MP0000858_altered_metastatic_potential | 0.99453761 |
| 86 | MP0008004_abnormal_stomach_pH | 0.98223673 |
| 87 | MP0009278_abnormal_bone_marrow | 0.97258152 |
| 88 | MP0005275_abnormal_skin_tensile | 0.97145507 |
| 89 | MP0001851_eye_inflammation | 0.95517844 |
| 90 | MP0001765_abnormal_ion_homeostasis | 0.94708544 |
| 91 | MP0008469_abnormal_protein_level | 0.93666745 |
| 92 | MP0009046_muscle_twitch | 0.93017681 |
| 93 | * MP0000716_abnormal_immune_system | 0.92942787 |
| 94 | MP0002006_tumorigenesis | 0.92842524 |
| 95 | MP0000681_abnormal_thyroid_gland | 0.92713660 |
| 96 | MP0002139_abnormal_hepatobiliary_system | 0.92602757 |
| 97 | MP0003329_amyloid_beta_deposits | 0.91820905 |
| 98 | MP0008569_lethality_at_weaning | 0.91316224 |
| 99 | MP0003705_abnormal_hypodermis_morpholog | 0.90759793 |
| 100 | MP0003763_abnormal_thymus_physiology | 0.90676537 |
| 101 | MP0001216_abnormal_epidermal_layer | 0.89764235 |
| 102 | MP0004130_abnormal_muscle_cell | 0.89514714 |
| 103 | MP0005390_skeleton_phenotype | 0.89481169 |
| 104 | * MP0002398_abnormal_bone_marrow | 0.87927720 |
| 105 | MP0000920_abnormal_myelination | 0.87781285 |
| 106 | MP0009764_decreased_sensitivity_to | 0.87432362 |
| 107 | MP0000013_abnormal_adipose_tissue | 0.86401062 |
| 108 | MP0003635_abnormal_synaptic_transmissio | 0.84638149 |
| 109 | MP0000343_altered_response_to | 0.82566925 |
| 110 | MP0005381_digestive/alimentary_phenotyp | 0.81794232 |
| 111 | MP0005501_abnormal_skin_physiology | 0.80805588 |
| 112 | MP0004270_analgesia | 0.80460759 |
| 113 | MP0003828_pulmonary_edema | 0.80404733 |
| 114 | MP0000003_abnormal_adipose_tissue | 0.80184046 |
| 115 | MP0008438_abnormal_cutaneous_collagen | 0.80165116 |
| 116 | MP0002933_joint_inflammation | 0.79038496 |
| 117 | MP0003633_abnormal_nervous_system | 0.78226504 |
| 118 | MP0009931_abnormal_skin_appearance | 0.78020635 |
| 119 | MP0002063_abnormal_learning/memory/cond | 0.77882946 |
| 120 | MP0002064_seizures | 0.76602589 |
| 121 | MP0001502_abnormal_circadian_rhythm | 0.76460317 |
| 122 | MP0003183_abnormal_peptide_metabolism | 0.75988795 |
| 123 | MP0010771_integument_phenotype | 0.75592190 |
| 124 | MP0001968_abnormal_touch/_nociception | 0.75001071 |
| 125 | MP0000465_gastrointestinal_hemorrhage | 0.74578960 |
| 126 | MP0002733_abnormal_thermal_nociception | 0.73307464 |
| 127 | MP0001970_abnormal_pain_threshold | 0.71349054 |
| 128 | MP0003283_abnormal_digestive_organ | 0.70255187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Obstructive sleep apnea (HP:0002870) | 4.73171455 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.17409727 |
| 3 | Pustule (HP:0200039) | 4.15736156 |
| 4 | Recurrent abscess formation (HP:0002722) | 3.44000802 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.08202805 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 3.05612472 |
| 7 | Increased IgE level (HP:0003212) | 3.02196439 |
| 8 | Neurofibrillary tangles (HP:0002185) | 2.97452687 |
| 9 | Cerebral inclusion bodies (HP:0100314) | 2.97032459 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 2.96694903 |
| 11 | Diplopia (HP:0000651) | 2.87114974 |
| 12 | Abnormality of binocular vision (HP:0011514) | 2.87114974 |
| 13 | Cellulitis (HP:0100658) | 2.85544300 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 2.81200502 |
| 15 | Distal lower limb muscle weakness (HP:0009053) | 2.79190375 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.70687484 |
| 17 | Dysostosis multiplex (HP:0000943) | 2.69881557 |
| 18 | Recurrent fungal infections (HP:0002841) | 2.66302213 |
| 19 | Cheilitis (HP:0100825) | 2.64480822 |
| 20 | Chronic otitis media (HP:0000389) | 2.63886328 |
| 21 | Gingivitis (HP:0000230) | 2.60385812 |
| 22 | Thick nail (HP:0001805) | 2.58761173 |
| 23 | Prostate neoplasm (HP:0100787) | 2.54678420 |
| 24 | Broad face (HP:0000283) | 2.53325643 |
| 25 | Inflammation of the large intestine (HP:0002037) | 2.52848191 |
| 26 | Plantar hyperkeratosis (HP:0007556) | 2.51611000 |
| 27 | Abnormality of macrophages (HP:0004311) | 2.51608527 |
| 28 | Fragile skin (HP:0001030) | 2.51161589 |
| 29 | Increased connective tissue (HP:0009025) | 2.50988321 |
| 30 | Hyperacusis (HP:0010780) | 2.50722284 |
| 31 | Axonal loss (HP:0003447) | 2.49335602 |
| 32 | Cerebral aneurysm (HP:0004944) | 2.48423808 |
| 33 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.44579551 |
| 34 | Systemic lupus erythematosus (HP:0002725) | 2.44391596 |
| 35 | Increased cerebral lipofuscin (HP:0011813) | 2.44018003 |
| 36 | Myokymia (HP:0002411) | 2.41307190 |
| 37 | Alopecia of scalp (HP:0002293) | 2.39605256 |
| 38 | Neuronal loss in central nervous system (HP:0002529) | 2.36219757 |
| 39 | Gastrointestinal inflammation (HP:0004386) | 2.35017328 |
| 40 | Visual hallucinations (HP:0002367) | 2.34947906 |
| 41 | Interstitial pulmonary disease (HP:0006530) | 2.33244751 |
| 42 | Stomatitis (HP:0010280) | 2.31957648 |
| 43 | Slow saccadic eye movements (HP:0000514) | 2.31640717 |
| 44 | Milia (HP:0001056) | 2.30536452 |
| 45 | Recurrent skin infections (HP:0001581) | 2.29993366 |
| 46 | Petechiae (HP:0000967) | 2.27860098 |
| 47 | Palmoplantar hyperkeratosis (HP:0000972) | 2.26446696 |
| 48 | Prolonged bleeding time (HP:0003010) | 2.26272391 |
| 49 | J-shaped sella turcica (HP:0002680) | 2.25714891 |
| 50 | Annular pancreas (HP:0001734) | 2.25681850 |
| 51 | Meningitis (HP:0001287) | 2.21938977 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 2.21333802 |
| 53 | Periodontitis (HP:0000704) | 2.19815999 |
| 54 | Recurrent cutaneous fungal infections (HP:0011370) | 2.18298393 |
| 55 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.18298393 |
| 56 | Hypercortisolism (HP:0001578) | 2.18240042 |
| 57 | Emphysema (HP:0002097) | 2.16867176 |
| 58 | Urticaria (HP:0001025) | 2.14109892 |
| 59 | Vasculitis (HP:0002633) | 2.13314557 |
| 60 | Colitis (HP:0002583) | 2.12749279 |
| 61 | Myocardial infarction (HP:0001658) | 2.10613650 |
| 62 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.09721866 |
| 63 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.08686555 |
| 64 | Mucopolysacchariduria (HP:0008155) | 2.08686555 |
| 65 | Ventricular fibrillation (HP:0001663) | 2.07548897 |
| 66 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.06913713 |
| 67 | Myositis (HP:0100614) | 2.06748331 |
| 68 | Supranuclear gaze palsy (HP:0000605) | 2.06205822 |
| 69 | Ankle clonus (HP:0011448) | 2.04290480 |
| 70 | Protrusio acetabuli (HP:0003179) | 2.03964220 |
| 71 | Gastrointestinal stroma tumor (HP:0100723) | 2.03700820 |
| 72 | Recurrent viral infections (HP:0004429) | 2.03637518 |
| 73 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.02876006 |
| 74 | Achilles tendon contracture (HP:0001771) | 2.02447236 |
| 75 | Thin bony cortex (HP:0002753) | 2.01835343 |
| 76 | Shallow orbits (HP:0000586) | 2.01808471 |
| 77 | Insomnia (HP:0100785) | 2.01497525 |
| 78 | Polygenic inheritance (HP:0010982) | 2.00528713 |
| 79 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.99544534 |
| 80 | Ventricular tachycardia (HP:0004756) | 1.98836247 |
| 81 | Obstructive lung disease (HP:0006536) | 1.98405980 |
| 82 | Chronic obstructive pulmonary disease (HP:0006510) | 1.98405980 |
| 83 | Lower limb amyotrophy (HP:0007210) | 1.97873418 |
| 84 | Increased variability in muscle fiber diameter (HP:0003557) | 1.95595113 |
| 85 | Verrucae (HP:0200043) | 1.95335772 |
| 86 | Papilloma (HP:0012740) | 1.95335772 |
| 87 | Palmar hyperkeratosis (HP:0010765) | 1.95323544 |
| 88 | Poikilocytosis (HP:0004447) | 1.94774061 |
| 89 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94205413 |
| 90 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.94205413 |
| 91 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94205413 |
| 92 | Menorrhagia (HP:0000132) | 1.93660591 |
| 93 | Atrophic scars (HP:0001075) | 1.93061802 |
| 94 | Glomerulonephritis (HP:0000099) | 1.91126412 |
| 95 | Reticulocytosis (HP:0001923) | 1.88487041 |
| 96 | Upper limb amyotrophy (HP:0009129) | 1.86235924 |
| 97 | Distal upper limb amyotrophy (HP:0007149) | 1.86235924 |
| 98 | Sepsis (HP:0100806) | 1.84848016 |
| 99 | Gingival bleeding (HP:0000225) | 1.84494308 |
| 100 | Sudden death (HP:0001699) | 1.84153650 |
| 101 | Focal motor seizures (HP:0011153) | 1.83988925 |
| 102 | Amyloidosis (HP:0011034) | 1.83263730 |
| 103 | Action tremor (HP:0002345) | 1.82004011 |
| 104 | Epistaxis (HP:0000421) | 1.81495187 |
| 105 | Hyperparathyroidism (HP:0000843) | 1.80744011 |
| 106 | Abnormality of nail color (HP:0100643) | 1.80275809 |
| 107 | Abnormality of the Achilles tendon (HP:0005109) | 1.80203756 |
| 108 | Nasal polyposis (HP:0100582) | 1.80009914 |
| 109 | Stridor (HP:0010307) | 1.78276692 |
| 110 | Abnormality of the nasal mucosa (HP:0000433) | 1.77954904 |
| 111 | Dysmetric saccades (HP:0000641) | 1.77841177 |
| 112 | Loss of speech (HP:0002371) | 1.77580076 |
| 113 | Peritonitis (HP:0002586) | 1.77485322 |
| 114 | Malnutrition (HP:0004395) | 1.76231796 |
| 115 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.75973355 |
| 116 | Polycythemia (HP:0001901) | 1.75923046 |
| 117 | Distal lower limb amyotrophy (HP:0008944) | 1.75845951 |
| 118 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.75770505 |
| 119 | Syncope (HP:0001279) | 1.75656725 |
| 120 | Orchitis (HP:0100796) | 1.75461369 |
| 121 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.75340912 |
| 122 | Dementia (HP:0000726) | 1.74857242 |
| 123 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.74758660 |
| 124 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.74180718 |
| 125 | Villous atrophy (HP:0011473) | 1.74180718 |
| 126 | Cervical subluxation (HP:0003308) | 1.74063214 |
| 127 | Agitation (HP:0000713) | 1.74032350 |
| 128 | Rigidity (HP:0002063) | 1.73890859 |
| 129 | Impaired platelet aggregation (HP:0003540) | 1.73680484 |
| 130 | Abnormal platelet function (HP:0011869) | 1.73680484 |
| 131 | Acanthocytosis (HP:0001927) | 1.71488586 |
| 132 | Agammaglobulinemia (HP:0004432) | 1.71397255 |
| 133 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.71331274 |
| 134 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.71331274 |
| 135 | Abnormality of glycolipid metabolism (HP:0010969) | 1.71331274 |
| 136 | Gastrointestinal infarctions (HP:0005244) | 1.71219767 |
| 137 | Hyporeflexia of lower limbs (HP:0002600) | 1.71164253 |
| 138 | Vertebral compression fractures (HP:0002953) | 1.70211215 |
| 139 | Nuclear cataract (HP:0100018) | 1.68873102 |
| 140 | Hypergammaglobulinemia (HP:0010702) | 1.68371903 |
| 141 | Nephritis (HP:0000123) | 1.68261953 |
| 142 | Mitral regurgitation (HP:0001653) | 1.66435444 |
| 143 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.66044076 |
| 144 | Increased serum ferritin (HP:0003281) | 1.65521762 |
| 145 | Spontaneous hematomas (HP:0007420) | 1.65250151 |
| 146 | Aneurysm (HP:0002617) | 1.64633992 |
| 147 | Onion bulb formation (HP:0003383) | 1.64590789 |
| 148 | Rapidly progressive (HP:0003678) | 1.63676682 |
| 149 | Global brain atrophy (HP:0002283) | 1.63656308 |
| 150 | Postural instability (HP:0002172) | 1.62747405 |
| 151 | Hypochromic anemia (HP:0001931) | 1.62380887 |
| 152 | Abnormality of the fingertips (HP:0001211) | 1.62273310 |
| 153 | Bulbar palsy (HP:0001283) | 1.60832272 |
| 154 | Hemorrhage of the eye (HP:0011885) | 1.59432384 |
| 155 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.58603821 |
| 156 | Easy fatigability (HP:0003388) | 1.58195237 |
| 157 | Abnormal blistering of the skin (HP:0008066) | 1.56650631 |
| 158 | Spinal canal stenosis (HP:0003416) | 1.56013919 |
| 159 | Ulnar bowing (HP:0003031) | 1.55231014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 4.41895810 |
| 2 | RIPK4 | 3.07207600 |
| 3 | PIK3CA | 2.72224404 |
| 4 | MAP3K2 | 2.66309164 |
| 5 | ERN1 | 2.50461648 |
| 6 | KSR2 | 2.33282229 |
| 7 | MAP4K1 | 2.26264619 |
| 8 | EPHB1 | 1.91972166 |
| 9 | SMG1 | 1.82548266 |
| 10 | MAP3K14 | 1.73732316 |
| 11 | TAOK3 | 1.72248860 |
| 12 | MAP3K1 | 1.69485543 |
| 13 | TBK1 | 1.65184659 |
| 14 | MAP2K3 | 1.61440000 |
| 15 | MAP2K2 | 1.58629771 |
| 16 | DMPK | 1.56213668 |
| 17 | BLK | 1.56106623 |
| 18 | ICK | 1.55047817 |
| 19 | IKBKE | 1.48838989 |
| 20 | TAOK2 | 1.48700770 |
| 21 | RIPK1 | 1.44518274 |
| 22 | JAK1 | 1.43786476 |
| 23 | MAP3K3 | 1.41451086 |
| 24 | TAOK1 | 1.40627055 |
| 25 | EPHA2 | 1.38185092 |
| 26 | TRIB3 | 1.34994594 |
| 27 | FES | 1.34136650 |
| 28 | CDK12 | 1.29405071 |
| 29 | CDC42BPA | 1.23270895 |
| 30 | SIK1 | 1.22531446 |
| 31 | WNK1 | 1.21178528 |
| 32 | CSK | 1.15842926 |
| 33 | TYK2 | 1.15642871 |
| 34 | MAPK12 | 1.15264592 |
| 35 | BMX | 1.14005533 |
| 36 | IKBKB | 1.13061589 |
| 37 | SIK2 | 1.12888942 |
| 38 | JAK2 | 1.09959698 |
| 39 | HIPK2 | 1.05740154 |
| 40 | ARAF | 1.05402636 |
| 41 | TRPM7 | 1.02245988 |
| 42 | CAMKK1 | 1.02052089 |
| 43 | MAP3K9 | 1.00256542 |
| 44 | MET | 0.99221330 |
| 45 | MAP2K1 | 0.98553706 |
| 46 | TTN | 0.97203293 |
| 47 | RET | 0.97167190 |
| 48 | RPS6KA2 | 0.96954551 |
| 49 | TGFBR2 | 0.95966613 |
| 50 | MAP3K13 | 0.95635250 |
| 51 | PRKD3 | 0.95061060 |
| 52 | MAPK15 | 0.94704343 |
| 53 | PIM2 | 0.94336552 |
| 54 | MAP3K7 | 0.93906959 |
| 55 | IRAK2 | 0.93865338 |
| 56 | TESK1 | 0.93593768 |
| 57 | HCK | 0.91448100 |
| 58 | PRKCH | 0.91391144 |
| 59 | NME2 | 0.90534176 |
| 60 | MAP3K11 | 0.90383945 |
| 61 | GRK6 | 0.89757136 |
| 62 | DAPK2 | 0.87063622 |
| 63 | MATK | 0.85136440 |
| 64 | IRAK4 | 0.84865842 |
| 65 | TNK2 | 0.84247985 |
| 66 | PTK6 | 0.83959731 |
| 67 | PRKD2 | 0.83954038 |
| 68 | SYK | 0.83727361 |
| 69 | NTRK1 | 0.81500954 |
| 70 | IRAK3 | 0.81323899 |
| 71 | EEF2K | 0.81086851 |
| 72 | JAK3 | 0.80515721 |
| 73 | UHMK1 | 0.77752617 |
| 74 | DDR2 | 0.77171240 |
| 75 | MAP3K10 | 0.75902543 |
| 76 | PRKG2 | 0.75744048 |
| 77 | RPS6KL1 | 0.75126882 |
| 78 | RPS6KC1 | 0.75126882 |
| 79 | MAPK7 | 0.75025748 |
| 80 | PDPK1 | 0.72532278 |
| 81 | PRPF4B | 0.71485757 |
| 82 | FGFR3 | 0.71325475 |
| 83 | CLK1 | 0.70069417 |
| 84 | PDK1 | 0.69251184 |
| 85 | MTOR | 0.68734430 |
| 86 | PDGFRA | 0.67391848 |
| 87 | CAMKK2 | 0.66686344 |
| 88 | FGFR4 | 0.66166322 |
| 89 | LATS2 | 0.66120055 |
| 90 | PTK2 | 0.65987078 |
| 91 | EPHA4 | 0.64521174 |
| 92 | ABL2 | 0.64317176 |
| 93 | DAPK3 | 0.63971199 |
| 94 | FRK | 0.63591594 |
| 95 | ZAP70 | 0.62799566 |
| 96 | MUSK | 0.62778271 |
| 97 | NTRK3 | 0.61018764 |
| 98 | RPS6KA6 | 0.60666796 |
| 99 | MAP3K6 | 0.60628255 |
| 100 | LCK | 0.59995901 |
| 101 | GRK5 | 0.58427279 |
| 102 | MARK2 | 0.57854301 |
| 103 | SGK3 | 0.57500632 |
| 104 | CHUK | 0.56624188 |
| 105 | MAP2K6 | 0.56527217 |
| 106 | MAPK4 | 0.56389726 |
| 107 | CAMK2D | 0.55567163 |
| 108 | NME1 | 0.55284398 |
| 109 | ITK | 0.55155029 |
| 110 | MARK3 | 0.54919190 |
| 111 | ALK | 0.54721873 |
| 112 | KIT | 0.54406783 |
| 113 | SIK3 | 0.54374990 |
| 114 | CAMK1 | 0.53769070 |
| 115 | TXK | 0.53755994 |
| 116 | PAK6 | 0.52395190 |
| 117 | STK10 | 0.52051917 |
| 118 | PRKCQ | 0.50061089 |
| 119 | BTK | 0.49980670 |
| 120 | LYN | 0.49915574 |
| 121 | PRKD1 | 0.49717664 |
| 122 | BRAF | 0.49191281 |
| 123 | DYRK1B | 0.49165796 |
| 124 | MAPKAPK5 | 0.49083032 |
| 125 | PKN2 | 0.49059056 |
| 126 | FYN | 0.48788649 |
| 127 | SGK223 | 0.47692321 |
| 128 | SGK494 | 0.47692321 |
| 129 | GRK7 | 0.47177357 |
| 130 | EPHA3 | 0.46953152 |
| 131 | CAMK1G | 0.46871407 |
| 132 | PDGFRB | 0.46679610 |
| 133 | STK11 | 0.46409134 |
| 134 | PTK2B | 0.45971732 |
| 135 | MAPKAPK3 | 0.44259155 |
| 136 | STK38 | 0.44052838 |
| 137 | CAMK2B | 0.43867466 |
| 138 | LRRK2 | 0.41960307 |
| 139 | CAMK2G | 0.41553057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.92925520 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 1.73434422 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.65988220 |
| 4 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.65349072 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61673019 |
| 6 | Mineral absorption_Homo sapiens_hsa04978 | 1.58280100 |
| 7 | Salivary secretion_Homo sapiens_hsa04970 | 1.48721344 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.41706559 |
| 9 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.32668813 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.32423671 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.26257173 |
| 12 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.24850725 |
| 13 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.24597530 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.24358862 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.23739613 |
| 16 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.20095298 |
| 17 | Prion diseases_Homo sapiens_hsa05020 | 1.19497236 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.18893170 |
| 19 | Salmonella infection_Homo sapiens_hsa05132 | 1.18597718 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17669969 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.16419060 |
| 22 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15547299 |
| 23 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.13047814 |
| 24 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.12582816 |
| 25 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.10468158 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.09363944 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07622213 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05469281 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02798555 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02744193 |
| 31 | Long-term potentiation_Homo sapiens_hsa04720 | 1.00793617 |
| 32 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.97509989 |
| 33 | Insulin secretion_Homo sapiens_hsa04911 | 0.97129522 |
| 34 | Platelet activation_Homo sapiens_hsa04611 | 0.97013929 |
| 35 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.96467300 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.96203657 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.95934935 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 0.95718981 |
| 39 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.95560663 |
| 40 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94685088 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.94215369 |
| 42 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.93054162 |
| 43 | Olfactory transduction_Homo sapiens_hsa04740 | 0.92824616 |
| 44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.92664277 |
| 45 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.91778408 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.91747321 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91505470 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.90796679 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89448467 |
| 50 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89439049 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89313716 |
| 52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.89060024 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88712952 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88642947 |
| 55 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.88547998 |
| 56 | Glioma_Homo sapiens_hsa05214 | 0.88241229 |
| 57 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.88205174 |
| 58 | Circadian entrainment_Homo sapiens_hsa04713 | 0.86523237 |
| 59 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.85358184 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.84105088 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83749675 |
| 62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83101172 |
| 63 | Malaria_Homo sapiens_hsa05144 | 0.82328052 |
| 64 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.82318215 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81039031 |
| 66 | Renin secretion_Homo sapiens_hsa04924 | 0.80999737 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80757706 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77820565 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.77549897 |
| 70 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.77382593 |
| 71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77283558 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.76855603 |
| 73 | Bladder cancer_Homo sapiens_hsa05219 | 0.76704248 |
| 74 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.76078871 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 0.75078429 |
| 76 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.75066668 |
| 77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.74991509 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.74964104 |
| 79 | Influenza A_Homo sapiens_hsa05164 | 0.73616501 |
| 80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.73270586 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.72647409 |
| 82 | Long-term depression_Homo sapiens_hsa04730 | 0.71973385 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.71617028 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70474108 |
| 85 | Morphine addiction_Homo sapiens_hsa05032 | 0.70352901 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70297707 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.70264647 |
| 88 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.69819410 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69655339 |
| 90 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.69433969 |
| 91 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.69244527 |
| 92 | Other glycan degradation_Homo sapiens_hsa00511 | 0.68590296 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67394233 |
| 94 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66662437 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65963359 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65899093 |
| 97 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65610211 |
| 98 | Shigellosis_Homo sapiens_hsa05131 | 0.65593785 |
| 99 | Measles_Homo sapiens_hsa05162 | 0.65500521 |
| 100 | Focal adhesion_Homo sapiens_hsa04510 | 0.65433061 |
| 101 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65423053 |
| 102 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64737236 |
| 103 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64348556 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.63456369 |
| 105 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62819782 |
| 106 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62217600 |
| 107 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62050715 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61036208 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.60976597 |
| 110 | Apoptosis_Homo sapiens_hsa04210 | 0.60228234 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59543098 |
| 112 | Cocaine addiction_Homo sapiens_hsa05030 | 0.59345898 |
| 113 | Hepatitis B_Homo sapiens_hsa05161 | 0.58843332 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58837916 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58075246 |
| 116 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57811562 |
| 117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57404695 |
| 118 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56826123 |
| 119 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56703591 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56095459 |
| 121 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54998299 |
| 122 | GABAergic synapse_Homo sapiens_hsa04727 | 0.54766085 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54043633 |

